MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · IEX Real-Time Price · USD
4.400
-0.230 (-4.97%)
Jul 19, 2024, 4:00 PM EDT - Market closed
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $459.99 million as of July 22, 2024. Its market cap has increased by 1.68% in one year.
Market Cap
459.99M
Enterprise Value
321.12M
1-Year Change
1.68%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $459.99M, a decrease of -48.72%. That is a compound annual growth rate of -20.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 460.00M | -5.51% |
| Dec 29, 2023 | 486.80M | -12.63% |
| Dec 30, 2022 | 557.20M | -45.55% |
| Dec 31, 2021 | 1.02B | 14.08% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Third Harmonic Bio | 483.61M |
| Cassava Sciences | 483.60M |
| Enhabit | 475.98M |
| Theravance Biopharma | 465.42M |
| Anavex Life Sciences | 463.84M |
| EyePoint Pharmaceuticals | 458.34M |
| Bioventus | 457.64M |
| Voyager Therapeutics | 455.27M |